Diagnostic nuclear medicine involves the use of radioactive tracers to image and/or measure the global or regional function of an organ. The radioactive tracer (radiopharmaceutical) is given to the ...
The general Nuclear Medicine program includes all areas of scintigraphic imaging, radionuclide therapy, use of radionuclides in the ascertainment of laboratory physiologic values, and proper ...
“With their higher specificity, these new tau imaging agents are ideal ... to create a universal scale for tau tracers.” The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear ...
The general Nuclear Medicine program includes all areas of scintigraphic imaging, radionuclide therapy, use of radionuclides in the ascertainment of laboratory physiologic values, and proper ...
Two new PET radiotracers have outperformed the only currently Food and Drug Administration (FDA) approved radiotracer for ...
The results of the studies indicate that the PET imaging agent may be a promising theranostic candidate for clinical use. The findings are published in the Journal of Nuclear Medicine. MTC is one ...
Why do we need DRLs in medical imaging? The optimization of patient protection in diagnostic radiology, diagnostic nuclear medicine or image guided interventional procedures requires the application ...
Scientists have developed two new imaging agents that work better than the only currently approved one for detecting tau ...
Trusted resource of information on Nuclear Medicine that includes articles, news, diet & nutrition, multimedia presentations, ...
Nuclear medicine focuses on the diagnostic, therapeutic and investigative use of radionuclides. Lastly, medical imaging creates computerized medical imaging and graphics. These are the world's top ...
Two new PET radiotracers have outperformed the only current Food and Drug Administration (FDA) approved radiotracer for detecting tau tangles in the brain, a hallmark of Alzheimer's disease. In a head ...